Gammaplex Related Published Studies
Well-designed clinical trials related to Gammaplex (Human Immunoglobulin G)
Intranasal vaccination with a replication-deficient influenza virus induces
heterosubtypic neutralising mucosal IgA antibodies in humans. [2014]
Evaluation of sex, race, body mass index and pre-vaccination serum progesterone
levels and post-vaccination serum anti-anthrax protective immunoglobulin G on
injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC
AVA human clinical trial. [2014]
Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following
vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle
vaccine. [2012]
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans. [2011.02]
Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral
boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S.
Typhi-specific IgA and IgG B memory cells in humans. [2011]
Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humans. [2010.12]
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica. [2010.11]
Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. [2010.09]
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers. [2010.04.30]
Reduction of PrP(C) in human cerebrospinal fluid after spinal cord injury. [2010.04]
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. [2010.01.08]
Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy
after lung transplantation. [2010]
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of
repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma. [2010]
Immunomodulatory effects of a standardized Lycium barbarum fruit juice in Chinese older healthy human subjects. [2009.10]
A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs. [2009.09]
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. [2009.08.06]
Alterations in the human lung proteome with lipopolysaccharide. [2009.05.11]
Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. [2009.04]
Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative study. [2009.01]
Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination. [2008.12.15]
Well-designed clinical trials possibly related to Gammaplex (Human Immunoglobulin G)
Efficacy and safety of sublingual immunotherapy for two seasons in patients with
Japanese cedar pollinosis. [2015]
Long-term efficacy of a hepatitis E vaccine. [2015]
A phase I/II placebo-controlled trial of C1-inhibitor for prevention of
antibody-mediated rejection in HLA sensitized patients. [2015]
A randomized, double-blind, placebo-controlled pilot study of sublingual versus
oral immunotherapy for the treatment of peanut allergy. [2015]
Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a
randomised, double-blind, placebo-controlled trial. [2015]
Remission induction comparing infliximab and high-dose intravenous steroid,
followed by treat-to-target: a double-blind, randomised, controlled trial in
new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). [2014]
Effect of reduced dose schedules and intramuscular injection of anthrax vaccine
adsorbed on immunological response and safety profile: a randomized trial. [2014]
Rates of serious infections, opportunistic infections, inflammatory bowel
disease, and malignancies in subjects receiving etanercept vs. controls from
clinical trials in ankylosing spondylitis: a pooled analysis. [2014]
Disease-activity-free status in patients with relapsing-remitting multiple
sclerosis treated with daclizumab high-yield process in the SELECT study. [2014]
Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis. [2014]
Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome
(LIPS): study protocol for a randomized controlled trial. [2014]
The comparative safety of tumor necrosis factor inhibitors in rheumatoid
arthritis: a meta-analysis update of 44 trials. [2014]
Clinically inactive disease in a cohort of children with new-onset polyarticular
juvenile idiopathic arthritis treated with early aggressive therapy: time to
achievement, total duration, and predictors. [2014]
Population exposure-response model to support dosing evaluation of ixekizumab in
patients with chronic plaque psoriasis. [2014]
Immune response and intestinal permeability in children with acute
gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized,
double-blind, placebo-controlled trial. [2014]
Development of Vi conjugate - a new generation of typhoid vaccine. [2013]
Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis. [2013]
Two year follow-up of clinical and inflammation parameters in children
monosensitized to mites undergoing subcutaneous and sublingual immunotherapy. [2013]
Evaluation of intravenous anthrax immune globulin for treatment of inhalation
anthrax. [2013]
Randomized clinical trial of arginine-supplemented enteral nutrition versus
standard enteral nutrition in patients undergoing gastric cancer surgery. [2013]
Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal
conjugate vaccines in reducing nasopharyngeal colonization: a randomized
double-blind trial. [2013]
Therapies for active rheumatoid arthritis after methotrexate failure. [2013]
The clinical efficacy of a bovine lactoferrin/whey protein Ig-rich fraction
(Lf/IgF) for the common cold: a double blind randomized study. [2013]
Etanercept in the treatment of ankylosing spondylitis: a meta-analysis of
randomized, double-blind, placebo-controlled clinical trials, and the comparison
of the Caucasian and Chinese population. [2013]
Clinical trial to evaluate safety and immunogenicity of an oral inactivated
enterotoxigenic Escherichia coli prototype vaccine containing CFA/I
overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. [2013]
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in
healthy infants and toddlers given with routine vaccines in India. [2013]
Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the
effect of IVIG--the ICE study. [2013]
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein
convertase subtilisin/kexin type 9 in combination with a statin in patients with
hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled,
dose-ranging, phase 2 study. [2012]
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein
convertase subtilisin/kexin type 9 as monotherapy in patients with
hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled,
phase 2 study. [2012]
Allergen-specific oral immunotherapy for peanut allergy. [2012]
Repeated low-dose intradermal allergen injection suppresses allergen-induced
cutaneous late responses. [2012]
Serum cotinine as a biomarker of tobacco exposure and the association with
treatment response in early rheumatoid arthritis. [2012]
The quantitative myasthenia gravis score: comparison with clinical,
electrophysiological, and laboratory markers. [2012]
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic
inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. [2012]
Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in
the setting of rituximab induced hypogammaglobulinemia. [2012]
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results
of a prematurely terminated trial. [2012]
Intravenous immunoglobulin therapy in adult patients with
polymyositis/dermatomyositis: a systematic literature review. [2012]
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. [2012]
Immunology in the Clinic Review Series; focus on allergies: basophils as
biomarkers for assessing immune modulation. [2012]
Immunology in the Clinic Review Series; focus on allergies: immunotherapy for
food allergy. [2012]
The safety and efficacy of sublingual and oral immunotherapy for milk allergy. [2012]
Assessment of health-related quality of life as an outcome measure in
granulomatosis with polyangiitis (Wegener's). [2012]
Long-term safety experience of ustekinumab in patients with moderate-to-severe
psoriasis (Part I of II): results from analyses of general safety parameters from
pooled Phase 2 and 3 clinical trials. [2012]
Challenges of clinical trial design when there is lack of clinical equipoise: use
of a response-conditional crossover design. [2012]
High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study). [2011.10]
Treatment of neonatal sepsis with intravenous immune globulin. [2011.09.29]
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. [2011.08.24]
Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial. [2011.08.06]
Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis. [2011.08]
Pneumococcal conjugate vaccination at birth in a high-risk setting: no evidence for neonatal T-cell tolerance. [2011.07.26]
Evaluation of Early Enteral Feeding Through Nasogastric and Nasojejunal Tube in Severe Acute Pancreatitis: A Noninferiority Randomized Controlled Trial. [2011.07.14]
Sleep after vaccination boosts immunological memory. [2011.07.01]
Cost utility analysis based on a head-to-head Phase 3 trial comparing ustekinumab and etanercept in patients with moderate-to-severe plaque psoriasis: a Canadian perspective. [2011.07]
Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi. [2011.07]
Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. [2011.07]
Efficacy of serology driven "test and treat strategy" for eradication of H. pylori in patients with rheumatic disease in the Netherlands. [2011.07]
Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. [2011.06.24]
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months. [2011.06.15]
Comparison of IVIg and PLEX in patients with myasthenia gravis. [2011.06.07]
Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial. [2011.06]
Etanercept compared to intraarticular corticosteroid injection in rheumatoid arthritis: double-blind, randomized pilot study. [2011.06]
Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. [2011.06]
Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia. [2011.05]
Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. [2011.05]
Impact of seroconversion and antichlamydial treatment on the rate of pre-eclampsia among Egyptian primigravidae. [2011.05]
99mTc-besilesomab (Scintimun) in peripheral osteomyelitis: comparison with 99mTc-labelled white blood cells. [2011.05]
Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). [2011.05]
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. [2011.05]
Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept. [2011.05]
Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial. [2011.05]
Ingestion of micronutrient fortified breakfast cereal has no influence on immune function in healthy children: a randomized controlled trial. [2011.04.21]
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. [2011.04.15]
Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D). [2011.04.11]
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. [2011.04.05]
Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine. [2011.04.05]
Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. [2011.04]
Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children. [2011.04]
Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. [2011.04]
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. [2011.04]
House dust mite sublingual immunotherapy: results of a US trial. [2011.04]
Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. [2011.04]
|